FDA DEVICE FACTS
Nitrile Powder Free Examination Glove, Blue Tested for Use with 32 Chemotherapy Drugs and Fentanyl Permeation Resistance Claim; Nitrile Powder Free Examination Glove, Violet Blue Tested for Use with 32 Chemotherapy Drugs, Xylazine, Fentanyl & Gastric Acid
Gmp Medicare Sdn. Bhd.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
A patient examination glove is a disposable dev ice intended for medical purpose that is worn on the examiner's hand or finger to prevent contamination between patient and examiner.
These gloves were tested for use with Chemotherapy Drugs as per ASTM D6978-05 standard practice for assessment of medical gloves to permeation by chemotherapy drugs:
Chemotherapy Drug Permeation The following chemicals have been tested with these gloves.
#
| # | Concentration Drugs Detection time in Minutes | Concentration (mg/ml) | Breakthrough |
|---|---|---|---|
| 1. | Amethopterin | 25.0 | >240 |
| 2. | Bleomycin Sulfate | 15.0 | >240 |
| 3. | Busulfan | 6.0 | >240 |
| 4. | Carboplatin | 10.0 | >240 |
| 5. | Carmustine | 3.3 | 11.0 |
| 6. | Cisplatin | 1.0 | >240 |
| 7. | Cyclophosphamide | 20.0 | >240 |
| 8. | Cytarabine | 100.0 | >240 |
| 9 | Dacarbazine | 10.0 | >240 |
| 10. | Docetaxel | 10.0 | >240 |
| 11. | Doxorubicin Hydrochloride | 2.0 | >240 |
| 12. | Ellence | 2.0 | >240 |
| 13. | Etoposide | 20.0 | >240 |
| 14. | Fludarabine | 25.0 | >240 |
| 15. | Fluorouracil | 50.0 | >240 |
| 16. | Gemcitabine | 38.0 | >240 |
| 17. | Idarubicin | 1.0 | >240 |
| 18. | Ifosfamide | 50.0 | >240 |
| 19. | Irinotecan | 20.0 | >240 |
| 20. | Mechlorethamine | 1.0 | >240 |
| 21. | Melphalan | 5.0 | >240 |
| 22. | Methotrexate | 25.0 | >240 |
| 23. | Mitomycin C | 0.5 | >240 |
| 24. | Mitoxantrone | 2.0 | >240 |
| 25. | Oxaliplatin | 5.0 | >240 |
| 26. | Paclitaxel | 6.0 | >240 |
| 27. | Rituximab | 10.0 | >240 |
| 28. | Thiotepa | 10.0 | 39.0 |
| 29. | Topotecan | 1.0 | >240 |
| 30. | Trisenox | 1.0 | >240 |
| 31. | Vincristine Sulfate | 1.0 | >240 |
| 32. | Vinorelbine | 10.0 | >240 |
| 33. | Fentanyl Citrate | 100 mcg/2mL | >240 |
Please note that Carmustine and Thiotepa have extremely low permeation times of 11 minutes and 39 minutes respectively.
Warning: Do not use with Carmustine and Thiotepa
Fentanyl Permeation Resistance Claim- Under the testing conditions of ASTM D6978-05, Fentanyl Citrate Injection (100mcg/2ml) was found to have no breakthrough detected up to 240 minutes
A patient examination glove is a disposable device intended for medical purpose that is worn on the examiner's hand or finger to prevent contamination between patient and examiner. These gloves were tested for use with Chemotherapy Drugs as per ASTM D6978-05 standard practice for assessment of medical gloves to permeation by chemotherapy drugs: Chemotherapy Drug Permeation The following chemicals have been tested with these gloves.
#
| # | Concentration Drugs Detection | Concentration (mg/ml) | Breakthrough time in Minutes |
|---|---|---|---|
| 1. | Amethopterin | 25.0 | >240 |
| 2. | Bleomycin Sulfate | 15.0 | >240 |
| 3. | Busulfan | 6.0 | >240 |
| 4. | Carboplatin | 10.0 | >240 |
| 5. | Carmustine | 3.3 | 10.0 |
| 6. | Cisplatin | 1.0 | >240 |
| 7. | Cyclophosphamide | 20.0 | >240 |
| 8. | Cytarabine | 100.0 | >240 |
| 9 | Dacarbazine | 10.0 | >240 |
| 10. | Docetaxel | 10.0 | >240 |
| 11. | Doxorubicin Hydrochloride | 2.0 | >240 |
| 12. | Epirubicin HCL | 2.0 | >240 |
| 13. | Etoposide | 20.0 | >240 |
| 14. | Fludarabine | 25.0 | >240 |
| 15. | Fluorouracil | 50.0 | >240 |
| 16. | Gemcitabine | 38.0 | >240 |
| 17. | Idarubicin | 1.0 | >240 |
| 18. | Ifosfamide | 50.0 | >240 |
| 19. | Irinotecan | 20.0 | >240 |
| 20. | Mechlorethamine | 1.0 | >240 |
| 21. | Melphalan | 5.0 | >240 |
| 22. | Methotrexate | 25.0 | >240 |
| 23. | Mitomycin C | 0.5 | >240 |
| 24. | Mitoxantrone | 2.0 | >240 |
| 25. | Oxaliplatin | 5.0 | >240 |
| 26. | Paclitaxel | 6.0 | >240 |
| 27. | Rituximab | 10.0 | >240 |
| 28. | Thiotepa | 10.0 | 30.0 |
| 29. | Topotecan | 1.0 | >240 |
| 30. | Trisenox | 1.0 | >240 |
| 31. | Vincristine Sulfate | 1.0 | >240 |
| 32. | Vinorelbine | 10.0 | >240 |
| 33. | Fentanyl Citrate | 100 mcg/2mL | >240 |
| 34. | Xylazine | 100 | >240 |
| 35. | Simulated Gastric Acid | N/A | >240 |
Please note that Carmustine and Thiotepa have extremely low permeation times of 10 minutes and 30 minutes respectively. Warning: Do not use with Carmustine and Thiotepa Gastric Acid Permeation Resistance Claim- Under the testing conditions of ASTM D6978-05, was found to have no breakthrough detected up to 240 minutes.
Xylazine Permeation Resistance Claim- Under the testing conditions of ASTM D6978-05, Xylazine HCl Injection (100 mg/ml) was found to have no breakthrough detected up to 240 minutes. Fentanyl Permeation Resistance Claim- Under the testing conditions of ASTM D6978-05, Fentanyl Citrate Injection (100mcg/2ml) was found to have no breakthrough detected up to 240 minutes.
| Characteristic | Standards | Device Performance |
|---|---|---|
| Dimension | ASTM D6319-19 (2023) | Meet |
| Physical Properties | ASTM D6319-19 (2023) | Meet |
| ASTM D6319-19 (2023) | Meet | |
| ASTM D6319-19 (2023) | Meet | |
| ASTM D6124-06 (2022) | Meet | |
| ASTM D6319-19 (2023) | Meet | |
| PrimarySkinIrritation (ISO 10993-10) | Passed Not a primary skin irritant under condition of the study | |
| SkinSensitization (ISO 10993-10) | Passed Not a contactsensitizer under the conditions of the study | |
| Acute Systemic Toxicity (ISO 10993-11) | Passed Underthe conditions ofthe study, therewas no evidence ofsystemic toxicity |
Tables marked from the FDA document were reconstructed automatically. Check the original FDA document (links at the end of this page) for authoritative values.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。